| Startup Opportunities in Biotechnology | April 27, 2011 |
Richard Scheller
|
Genentech |
Entrepreneurial Thought Leaders Lecture Series |
| Views: 823 |
|
| Video 7 of 9 from this talk |
- 59:37Developing Products that Save Lives [Entire Talk]
- 05:05Moving From Academia to Industry
- 03:18Choose Your Words Carefully
- 05:06Drug Development Process
- 03:26Pharmaceutical Market Realities
- 02:51Encouraging Innovation and Risk Taking
- 03:36Startup Opportunities in Biotechnology
- 04:41Motivating a Biotechnology Workforce
- 04:40Ethical Issues in Drug Development
Description
Richard Scheller, Genentech's Executive Vice President of Research and Early Development, believes it is unlikely, if not impossible, for small companies to push drug products through the final stage of development. However, Scheller also thinks a smart biotechnology startup could do early stage development and then turn to larger firms for product licensing or acquisition. Scheller also discusses the state of research and development at Genentech, in comparison to other firms.
Comments 
Related Videos:
